Volume 85 Issue 9 | p. 25 | Concentrates
Issue Date: February 26, 2007

Germany's Merck Shifts Head Again

Department: Business

Merck KGaA has named Karl-Ludwig Kley as chairman, effective April 27. Kley replaces Michael Roemer, a longtime company executive who took the position in November 2005 following the abrupt departure of Bernhard Scheuble. Kley, who has been vice chairman of Merck's executive board since last September, is credited as an architect of the company's new pharmaceutical division, Merck Serono.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment